HealthStream, Inc. — 2014 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2014. Although requested as 2014 Q4, this filing is an annual report; fourth-quarter results are shown separately below. HealthStream provides SaaS workforce-development solutions and healthcare research and patient-experience services. At year-end, it reported 4.28 million total subscribers, including 4.15 million implemented subscribers.
Financial results
| Metric | FY 2014 | FY 2013 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Revenue | $170.7 million | $132.3 million | $45.3 million | $37.1 million |
| Operating income | $16.4 million | $14.7 million | $4.2 million | $3.5 million |
| Net income | $10.4 million | $8.4 million | $2.6 million | $1.8 million |
| Diluted EPS | $0.37 | $0.30 | $0.09 | $0.06 |
| Operating margin | 9.6% | 11.1% | 9.3% | 9.5% |
- Full-year revenue grew 29.0%; operating income rose 11.7% and net income rose 23.4%. Adjusted EBITDA, a non-GAAP measure, increased 20.6% to $28.9 million.
- Workforce Development revenue grew 33.7% to $138.8 million; Research/Patient Experience revenue increased 12.1% to $31.9 million. Workforce Development supplied 81% of revenue.
- Subscription-based products represented approximately 76% of revenue. Implemented subscribers increased 22.4%, and annualized revenue per implemented subscriber rose 6.2% to $34.43.
- Cost of revenue excluding depreciation and amortization rose to 43.4% of revenue from 42.0%; management cited higher courseware royalties and personnel costs. Full-year operating margin declined despite revenue growth.
- Cash provided by operations was $34.3 million, up from $27.1 million. Cash and marketable securities totaled approximately $121.0 million; working capital was $97.4 million. The company had no debt outstanding and all $50 million of its revolving facility available at year-end.
Changes, outlook and notable items
- ICD-10 readiness training revenue rose to $28.4 million from $13.9 million and materially supported 2014 growth. Management warned that subscriptions may expire in 2015–2016 and customers may not renew at similar levels, creating potential revenue pressure.
- HealthStream acquired HCCS in March 2014; its reported 2014 revenue contribution was approximately $4.8 million. The acquisition produced a $1.5 million deferred-revenue fair-value write-down, reducing reported revenue relative to the acquired contracts’ prior book value.
- In February 2015, the company agreed to acquire HealthLine Systems for approximately $88 million in cash, subject to closing conditions. It expected to fund the purchase with approximately $60 million of cash and $28 million of borrowing.
- 2015 guidance, including the estimated HealthLine contribution, projected consolidated revenue growth of 18%–21%, but operating income 25%–35% below 2014. The expected decline included $5–$7 million of acquired deferred-revenue write-downs, about $1 million in transaction costs, and higher product-development and sales-and-marketing investment. Expected HealthLine revenue was $7–$9 million, assuming a March 31 closing.
- Management forecast 2015 capital expenditures of $11–$14 million and an effective tax rate of 42%–44%. It expected NOL carryforwards to be fully used during 2015, increasing cash tax payments thereafter.
- Cash-flow presentation for acquisition earn-out payments was reclassified from operating to financing activities; management characterized the prior-period adjustment as an immaterial correction. The 2014 audit opinion was unqualified, and management and the auditor reported effective internal control over financial reporting.
Risks and contingencies
- Revenue depends on customer renewals, subscriber adoption and usage, and survey timing; contracts generally do not require renewal, and customer concentration is significant although no single customer exceeded 10% of revenue.
- Key exposures include healthcare-sector spending and competition, reliance on content and strategic partners, technology outages and cybersecurity or privacy breaches, regulatory and accreditation requirements, and the ability to integrate acquisitions.
- Goodwill and identifiable intangible assets totaled approximately $56.7 million at year-end and are exposed to impairment risk; no impairment was recorded in 2014. The filing identifies ordinary-course legal matters but says management did not expect pending or threatened matters to materially affect financial position or results. Item 3 reports no material legal proceedings.
Important facts for investors to verify
- Whether ICD-10 courseware renewals and subscriber revenue per implemented user offset the expiration of temporary training demand.
- HealthLine’s closing, integration, actual revenue contribution, deferred-revenue accounting impact, and resulting debt and interest costs.
- Whether research/patient-experience profitability improves: segment operating income fell to $0.8 million from $2.8 million despite revenue growth.
- Cash conversion and collections: days sales outstanding increased to 63 from 56, while operating cash flow benefited from higher deferred revenue.
- Reported GAAP results versus adjusted EBITDA and other non-GAAP measures, including the acquisition-related deferred-revenue adjustments.